作者
Kenneth F Schulz, Douglas G Altman, David Moher
发表日期
2010/12
期刊
Journal of Pharmacology and pharmacotherapeutics
卷号
1
期号
2
页码范围
100-107
出版商
SAGE Publications
简介
Randomised controlled trials, when appropriately designed, conducted and reported, represent the gold standard in evaluating healthcare interventions. However, randomised trials can yield biased results if they lack methodological rigour.[1] To assess a trial accurately, readers of a published report need complete, clear and transparent information on its methodology and findings. Unfortunately, attempted assessments frequently fail because authors of many trial reports neglect to provide lucid and complete descriptions of that critical information.[2-4]
That lack of adequate reporting fuelled the development of the original CONSORT (Consolidated Standards of Reporting Trials) statement in 1996 [5] and its revision five years later.[6-8] While those statements improved the reporting quality for some randomised controlled trials,[9, 10] many trial reports still remain inadequate.[2] Furthermore, new methodological …
引用总数
201020112012201320142015201620172018201920202021202220232024166559803101811711222132513581558169120352197231423981362
学术搜索中的文章
KF Schulz, DG Altman, D Moher, V Barbour, JA Berlin… - Japanese Pharmacology and Therapeutics, 2015
KF Schulz, DG Altman, D Moher, V Barbour, JA Berlin… - Japanese Pharmacology and Therapeutics, 2017
KF Schulz, DG Altman, D Moher, DG Altman, V Barbour… - Japanese Pharmacology and Therapeutics, 2014